The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Peptides Lack Reliable Safety Information, Watchdog Warns The Peptide Boom Is Getting Out of Hand The Atlantic The wellness world is eager for RFK Jr.'s promised move on peptides : NPR